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MATERNAL AND FETAL OUTCOME  
IN RENAL TRANSPLANT RECIPIENTS 
Wajeeha Syed1, Louman Sheikh2
CASE SERIES
INTRODUCTION
Renal transplantation is the best option to restore 
fertility in women with end stage renal failure1,2. This 
is due to correction of endocrine function post trans-
plantation3. Although these pregnancies are successful 
in 90% of cases, there is still high chance of maternal 
and neonatal complications such as pre-eclampsia, ges-
tational diabetes, preterm births and small for gesta-
tional age fetuses4,5. Premature births (<37 weeks) and 
low birth weight are among the most common neonatal 
complications. However studies have shown that mater-
nal and neonatal outcomes remain favourable with suc-
cessive pregnancies in renal transplant recipients6. For 
those with pre-pregnancy serum creatinine of >1.7mg/
dl, there are higher chances of deterioration of renal 
function after pregnancy7.
In this study we describe our experience in Aga Khan 
University Hospital, Karachi, Pakistan about pregnan-
cy outcome in renal transplant recipients and present 
a retrospective study for the period 2005-2015. This 
will create awareness among obstetricians dealing with 
such pregnancies about the expected maternal and fe-
tal outcomes and will also be helpful in proper coun-
seling of the patients and their families. Also upto our 
knowledge this is only one of the two studies conduct-
ed on this topic in Pakistan so we are able to generate 
our local data.
METHODOLOGY
Records of patients who had pregnancy with renal 
transplant and had antenatal checkups, delivery and 
postpartum nephrology follow up at our hospital were 
retrospectively reviewed between January 1st 2005 till 
December 31st 2015. Women who became pregnant 
before renal transplantation or ongoing dialysis or who 
were lost to follow up regarding renal status after deliv-
ery were excluded.
This study received approval from ethical review 
committee of Aga Khan University Hospital Karachi. The 
medical records were reviewed including maternal age 
at delivery, underlying cause of renal failure, peritoneal 
or hemodialysis, duration between transplantation and 
pregnancy, serum creatinine levels, birth weight, ges-
tational age, birth weight centile and Apgar scores at 
1 and 5 minutes. Maternal and neonatal complications 
such as pre-eclampsia, gestational diabetes, anemia, 
urinary tract infection, small for gestational age, pre-
maturity, mode of delivery and neonatal intensive care 
unit admission were also collected on a structured pro-
forma. Data was entered and analyzed in SPSS version 
20. Mean and standard deviation were calculated for 
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ABSTRACT
Objective: To determine maternal and fetal outcome in renal transplant recip-
ients.
Methodology: Retrospective analysis of the antenatal patients with renal trans-
plant was done between January 1st 2005 till December 31st 2015 and maternal 
and fetal outcomes were determined. Data was entered and analyzed in SPSS 
version 20. 
Results: 08 pregnancies in 07 women who had undergone renal transplant 
were included in this study. The mean age at the time of transplantation was 
25.29 ±5.5 years (16-32 years). 25% cases had gestational diabetes mellitus, 
75% had anemia and 50% had urinary tract infection. The mean birth weight 
of babies was 2210 ±.638 grams (range1500-3400g). Preterm deliveries com-
prised 37.5% before 34 weeks and 50% after 34 weeks. 37.5% of the neonates 
needed neonatal intensive care unit admission.
Conclusion: Pregnancy after renal transplant is safe for mother, fetus and the 
graft.
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Table 1: Maternal transplant related data
S.
No. Underlying Disease
Hemo- 
Dialysis 
(HD)
Age at 
Trans-
planta-
tion
Immunosuppressants use 
in Pregnancy
Age at 
Delivery
Duration 
from Trans-
plantation
 to Preg-
nancy
1 Hypertensive nephropathy HD 27 years Cyclosporin, Azathioprine 29 years 2 years
2 ------------ ----- 16 years Azathioprine, Prednisolone 20 years 4 years
3 Hypertensive nephropathy HD 32 years Azathioprine, Prednisolone, Cyclosporin 36 years 4 years
4 IgA nephropathy HD 22 years Azathioprine, Prednisolone 23 years 2 years
5 IgA nephropathy HD 22 years Azathioprine, Prednisolone,Cyclosporin 30 years 9 years
6 ---------- ------ --------- Azathioprine, Prednisolone,Cyclosporin 35 years 2 years
7 Hypertensive nephropathy HD 30 years Azathioprine, Prednisolone,Cyclosporin 33 years 3 years
8 Hypertensive nephropathy HD 28 years Azathioprine, Prednisolone,Cyclosporin 35 years 7 years
Table 2: Maternal co-morbidities
S.
No.
Hypertension 
prior to preg-
nancy
Pre- 
Eclampsia
Gestational 
Diabetes 
(GDM)
Ane-
mia UTI
Graft 
loss
S. Creat. 
prior to 
pregnancy 
(in mg/dl)
Postpartum 
S.Creat.
 (in mg/dl)
1 Yes No Type 2 DM Yes No Nil 0.8 01
2 Yes No No Yes No Nil 0.9 1.5
3 Yes No GDM Yes Yes Nil 01 0.9
4 Yes No No No Yes Nil 0.9 0.93
5 Yes No No No Yes Nil 0.9 0.9
6 Yes No GDM Yes Yes Nil 1.1 0.9
7 Yes No No Yes No Nil 01 1.2
8 Yes No No Yes No Nil 2.3 2.8
continuous variables. Frequency and percentages were 
calculated for categorical variables.
RESULTS
08 pregnancies in 07 women who had undergone 
renal transplant were included in this study. All of the 
pregnancies were conceived naturally.The mean age 
of the patients at the time of delivery was 30.13 ±5.9 
years (range 20 -36 years). The mean age at the time 
of transplantation was 25.29 ±5.5 years (16-32 years). 
Immunosuppressant therapy comprised cyclosporine, 
azathioprine and prednisolone.
The mean gestational age was 34.87 ±1.8 weeks. 
The mean birth weight of babies was 2210 ±.638 grams 
(range1500-3400g). Preterm deliveries comprised 
37.5% before 34 weeks and 50% after 34 weeks. 37.5% 
of the neonates needed neonatal intensive care unit 
(NICU) admission. 37.5% were normal vaginal deliveries 
and 62.5% were delivered by cesarean section. There 
was no miscarriage and only 01 fetus had ventricular 
septal defect.
The mean serum creatinine level prior to pregnancy 
was 1.1 ±.48mg/dl (range 0.8-2.3mg/dl) and after preg-
nancy it was 1.2 ±.65 (range 0.9-2.8mg/dl). All of the pa-
tients had hypertension prior to pregnancy while there 
was no case of superimposed pre-eclampsia. 25% cases 
had gestational diabetes mellitus ,75% had anemia and 
50% had urinary tract infection. There was no case of 
graft loss uptill one year after delivery.
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Table 3: Pregnancy outcomes
S.
No.
Gestational Age 
(in weeks) Baby Sex
Birth Weight 
(in kg)
Birth Weight 
(centile)
Apgar Score 
(at 1 min.)
Apgar Score 
(at 5 min.)
1 33 Female 1.5 1.1 8 9
2 33 Male 1.7 1.3 8 9
3 36 Male 2.3 31.1 6 9
4 35 Male 2.4 41.9 8 9
5 36 Male 2.7 24 8 9
6 38 Male 3.4 68 8 9
7 35 Female 1.6 06 8 9
8 33 Female 2.08 20 8 9
DISCUSSION
Our review of the pregnancies after renal transplant 
favours the findings of previous studies on same topic.
Transplanted kidney does not usually obstruct the birth 
channel and vaginal delivery can be accomplished in 
most cases if there are no maternal or fetal contrain-
dications. The cesarean section rate in our study was 
62.5% mainly due to obstetrical reasons. Cesarean rate 
of 55% reported by Ducrame etal8 and 50% by Bouttar 
et al5 are also mainly due to obstetrical indications. 
Maternal renal transplant patients with hyperten-
sion are at an increased risk of superimposed pre-ec-
lampsia. In our analysis hypertension before pregnancy 
was present in all cases but there was no case of su-
perimposed pre-eclampsia. Other studies quot figure 
of 70% for hypertension before pregnancy and 30-40% 
for pre-eclampsia9.The difference may be explained by 
small sample of our study and also because of good 
control of blood pressure during pregnancy with only 
one antihypertensive agent.
 02 out of total 8 patients (25%) had gestational 
diabetes while a rate of 13.3% was found in a study 
conducted in Taiwan10. Use of steroid is one of the pre-
disposing factor for the development of gestational di-
abetes in patients with renal transplant.
 Renal transplant recepients are at an increased risk 
of infections during pregnancy, especially bacterial uri-
nary tract infections and acute pyelonephritis of the 
graft. Anemia is common in renal transplant recepi-
ents especially iron deficiency due to increase use of 
iron after transplant. Erythropoeitin production from a 
well functioning allograft begins and sustains to normal 
within a month after transplantation11. There was a high 
frequency of anemia and urinary tract infection in our 
study. This corresponds with the results of 40% anemia 
by del Mar Colon et al12 and Bouattar et al5 who found 
anemia in 80% and urinary tract infection in 20%. No 
patient in our case however needed erythropoietin or 
blood transfusion and all the patients responded well 
to iron therapy. 
Table 4: Perinatal co-morbidities
S.
No.
Sponta-
neous
Miscar-
riage
Congen-
ital
Anomaly
Preterm 
<34 weeks
Preterm 
34-37 
weeks
Stillbirth Mode of Delivery
Reason 
for Cesar-
ean
NICU ad-
mission
1 Nil Nil Yes No Nil C/S* IUGR** Yes
2 Nil Nil Yes No Nil C/S IUGR Yes
3 Nil Nil No Yes Nil C/S Previous 2 cesareans Nil
4 Nil Nil No Yes Nil SVD*** ------ Nil
5 Nil Nil No Yes Nil SVD ------ Nil
6 Nil VSD*** No No Nil C/S ------ Nil
7 Nil Nil No Yes Nil C/S Previous 1 cesarean Yes
8 Nil Nil Yes No Nil SVD -------- Nil
* C/S= cesarean section, ** IUGR= intra-uterine growth restriction, ***SVD= spontaneous vaginal delivery  
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Prematurity and its associated risks are the main 
issue in babies born to renal transplant recepients. 
About 37.5% fetuses were born premature before 34 
weeks and 50% were born premature after 34 weeks 
with NICU admission rate of 37.5% due to severe intra-
uterine growth restriction. Prematurity rate of 33-60% 
has been reported in other studies13,14. Use of cyclospo-
rine and azathioprine may account for low birth weight 
and prematurity15. Pregnancy outcome depends on 
pre-pregnancy serum creatinine level7. No miscarriage 
was observed in our study similar to other studies which 
show that 95% gestations end successfully16. In one of 
a local study there were15 miscarriages out of total 68 
patients17.However these pregnancies were unplanned 
and conceived with high baseline serum creatinine.
There was only one case of ventricular septal defect in 
our study. Very few studies in literature report associa-
tion of congenital heart defect with azathioprine. The 
rate of malformation is however not higher than in gen-
eral population18. 
The patients in our study had a relatively short inter-
val between transplantation and pregnancy (4.13 ±2.588 
years). Thompson et al19 found a mean time of 6.5 years 
in 48 cases and concluded that early pregnancies after 
transplantation had a poor prognosis. But our findings 
differed from their results. We did not observe acute re-
jection episode and the serum creatinine level remained 
stable during pregnancy as reported by Bouattar et al5. 
Stable graft function and base line serum creatinine 
before pregnancy accounts for this. Lindheimer et al20 
noted 5% acute rejection episodes.
CONCLUSION
Pregnancy after renal transplant is safe for mother, 
fetus and the graft but multidisciplinary approach is 
needed to prevent complications.
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